![](/wp-content/uploads/2020/11/Lilly-Ypsomed-Tidepool.png)
$599
Lilly Partners with Ypsomed for AID System; Tidepool Lays Off 40% of Staff
Two diabetes-related news items have been observed: Lilly and Ypsomed announced a partnership for the commercialization of Ypsomed’s AID system and Tidepool announced layoffs accounting for 40% of their staff. Below, FENIX provides highlights and insights for the respective news items, including thoughts on if the Lilly/Ypsomed partnership may be an admission from Lilly that its AID development is behind expectations and how the material experience of Mike Mason may have contributed to this deal getting done.